SEAN O'LAUGHLIN: Open Payments
NPI 1235505439 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,861 in 70 payments from 11 companies in 2025. Trend: 2023 $6,911 · 2024 $8,083 · 2025 $6,861
Speaker / faculty: $5,500Food & beverage: $1,211Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $5,854 |
| Alexion Pharmaceuticals, Inc. | 5 | $222 |
| Biogen, Inc. | 2 | $168 |
| Lundbeck LLC | 2 | $150 |
| UCB, Inc. | 7 | $146 |
| PFIZER INC. | 5 | $115 |
| Axsome Therapeutics, Inc. | 4 | $78 |
| Janssen Biotech, Inc. | 2 | $42 |
| SK Life Science, Inc. | 2 | $39 |
| ANI Pharmaceuticals, Inc. | 1 | $28 |
Products named: QULIPTA, UBRELVY, ULTOMIRIS, VYEPTI, TYSABRI, NURTEC ODT, Rystiggo, Symbravo.
Industry payments across VA — which companies pay providers there.
